Patent details

Basic Information

Publication number:

EP2416778

PCT Application Number:

PCT/US/2010/029943

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP107126757

PCT Publication Number:

WO/2010/117941

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION BASED ON ABCC2 GENE SEQUENCE OR PRODUCT THEREOF

French Title of Invention:

PROCEDE DE PREDICTION DE LA PREDISPOSITION A UNE ELONGATION DE L'INTERVAL QT BASE SUR LE GENE ABCC2 OU DE CES PRODUITS

German Title of Invention:

VERFAHREN ZUR VORHERSAGEN DER VERANLAGUNG ZUR QT VERLÄNGERUNG BASIEREND AUF ABCC2 GENSEQUENZ ODER PRODUKTE DAVON

SPC Number:

Dates

Filing date:

05/04/2010

Grant date:

02/03/2016

EP Publication Date:

02/03/2016

PCT Publication Date:

14/10/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/02/2012

EP B1 Publication Date:

02/03/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/04/2016

Expiration date:

05/04/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/04/2010

 

 

Name:

Vanda Pharmaceuticals Inc.

Address:

2200 Pennsylvania Avenue Suite 300-E, Washington, DC 20037, United States (US)

Inventor

1

Name:

VOLPI Simona

Address:

United States (US)

2

Name:

LICAMELE Louis

Address:

United States (US)

3

Name:

LAVEDAN Christian

Address:

United States (US)

Priority

Priority Number:

167139 P

Priority Date:

06/04/2009

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/519;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages